Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction'. Together they form a unique fingerprint.
Monocrotaline
Medicine & Life Sciences
100%
Pulmonary Hypertension
Medicine & Life Sciences
69%
Mesenchymal Stem Cells
Medicine & Life Sciences
62%
Lung
Medicine & Life Sciences
27%
Vascular Resistance
Medicine & Life Sciences
23%
Acetylcholine
Medicine & Life Sciences
17%
Smooth Muscle
Medicine & Life Sciences
11%
Arterial Pressure
Medicine & Life Sciences
10%
Cite this